Viatris (VTRS) Other financing activities (2019 - 2026)

Viatris (VTRS) recorded quarterly Other financing activities of -$300000.0 in Q1 2026, up 99.84% quarter-over-quarter from -$191.4 million in Q4 2025, and up 99.73% on a YoY basis from -$150205.6 in Q1 2025.

Viatris (VTRS) Other financing activities (2019 - 2026) Analysis & Trends

Viatris' Other financing activities history runs 8 years deep, the most recent figure standing at -$300000.0 for Q1 2026.

  • In Q1 2026, Other financing activities rose 99.73% year-over-year to -$300000.0; the TTM figure through Mar 2026 stood at -$80.8 million (down 145.04% YoY), while the FY2025 annual figure was -$190.1 million, down 164.4% from the prior year.
  • Other financing activities was -$300000.0 for Q1 2026 at Viatris, up from -$191.4 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $290.4 million in Q4 2024 to a low of -$277.2 million in Q4 2023.
  • Historically, Other financing activities has averaged -$3.1 million across 5 years, with a median of $4.0 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Other financing activities surged 6000.0% in 2023, then slumped 1867.74% in 2025.
  • A 5-year view of Other financing activities shows it stood at $17.0 million in 2022, then tumbled by 1730.59% to -$277.2 million in 2023, then jumped by 204.76% to $290.4 million in 2024, then slumped by 165.91% to -$191.4 million in 2025, then jumped by 99.84% to -$300000.0 in 2026.
  • The last three Other financing activities figures came in at -$300000.0 (Q1 2026), -$191.4 million (Q4 2025), and $156.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Viatris - - 1.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -300,000.00
Mar 31, 2026 -300,000.00
Dec 31, 2025 -191.40 Mn
Dec 31, 2025 -191.40 Mn
Sep 30, 2025 156.30 Mn
Sep 30, 2025 156.30 Mn
Jun 30, 2025 -45.40 Mn
Jun 30, 2025 -45.40 Mn
Mar 31, 2025 -109.60 Mn
Mar 31, 2025 -109.60 Mn
Dec 31, 2024 290.40 Mn
Dec 31, 2024 290.40 Mn
Sep 30, 2024 -124.00 Mn
Sep 30, 2024 -124.00 Mn
Jun 30, 2024 122.60 Mn
Jun 30, 2024 122.60 Mn
Mar 31, 2024 6.20 Mn
Mar 31, 2024 6.20 Mn
Dec 31, 2023 -277.20 Mn
Dec 31, 2023 -277.20 Mn